Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

Conditions: Glioblastoma Interventions: Drug: PEP-CMV vaccine Sponsors: Charlotte Lemech; The University of New South Wales Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials